GRM2 and glioblastoma: Studies have exhibited that more expression of mGluR3 implicates a higher malignancy of tumors and a higher fatality [45], consistent with the result of D’Alessandro, G., et al., who reported the inhibition of GBM proliferation caused by the block of mGluR2/3 [42].